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ABSTRACT 
Lung spirometry data from three working-class industry populations were analyzed using 
logistic and linear regression to see if seasonality adversely affected test outcomes. Populations 
included emergency responders, general industry, and shipwrights. The data was organized into 
allergy and non-allergy seasons using NOAA meteorological data and regression and logistic 
analysis was run on these separate populations to test for demographic and seasonal effects on 
lung spirometry test outcomes. The American Thoracic Society gold standard was as a point for 
determining impaired lung function (FEV1/FVC > 0.80). It was found that seasonality imparted a 
slight linear effect on the predictive values of FEV1 and FVC for determining impaired lung 
function FEV1 and FVC values were Pr > 0.0003 and Pr > 0.0002, respectively. For demographic 
variables, age imparted the greatest linear effect for FEV1 and FVC,  with significant p-values of 
0.0002 and <0.0001, respectively. 
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CHAPTER ONE: 
INTRODUCTION 
An often seemingly benign and under-played problem effecting millions throughout the 
United States, daily, are allergies. More than 50 million Americans suffer from this chronic 
illness; totaling up to a cost of $18 billion dollars annually (CDC.gov, 2011).  While many of us 
know someone in our families or amongst our friends with allergies, this seems to be seen as 
commonplace and is often not looked into any further concerning possible further ramifications 
or consequences other than a continued and mild annoyance for the sufferer.  
Allergies are the result of an over-responsive immune system reacting to seemingly 
harmless substances that would normally elicit a biological response in a human (CDC.gov, 
2011). These responses range from coughing, sneezing, runny nose, and even hives or difficulty 
breathing. All ages are at risk for allergies. Given the wide variety of genetic make up for 
individuals as well as the nature of allergies, it is becoming more uncommon to find individuals 
that do not have some sort of allergy or sensitization. Allergies can range from an in-born allergy 
an infant may have to cow’s milk or an adult male that has reoccurring allergic dermatitis when 
coming in contact with latex (CDC.gov, 2011). Allergies can also differ in their nature; being 
that they can be seasonal, which is typically limited to pollen produced in growing seasons by 
specific plants or from mold spores. Allergies can also be perennial, causing allergy sufferers to 
be affected year-round by dust mites, pet hair or dander, cockroaches, or molds (ACCAI.org, 
2 
2014).  There are noted differences between the specific types of illnesses that allergies can 
cause. Contact dermatitis occurs when a specific allergen makes physical contact with the skin or 
mucosa and the skin reacts by swelling and turning red. Allergic rhinitis is associated with runny 
nose and itchy, watery eyes and is most often concurrent with pollen blooms in allergy seasons. 
Occupational rhinitis and dermatitis are associated with occupational contact with aggravating 
dusts, allergens, or chemicals that can sensitize individuals that come in contact with them. 
Allergic rhinitis, the most common of these, is often overlooked due to this very reason.  
From an occupational standpoint, asthma and allergies can be debilitating to workers, 
potentially leading them to fail lung spirometry tests and suffer from distracting symptoms while 
at work.  Lung spirometry is used in the industry as a form of health surveillance and can often 
detect if any workers are developing prodromal symptoms relating to their occupation 
(CDC.NIOSH.gov, 2011). Because of underlying allergy symptoms, these tests can give false 
positives and be misleading to Risk Management and health sections in the industry. As a result, 
workers could potentially fail fitness tests and be labeled as unfit for duty, even though they may 
not be at risk for occupational illnesses. The goal of this research is to investigate if there is an 
increase in workers failing lung spirometry tests coinciding with allergy seasons in the 
Southeastern United States.  
Pulmonary Function Tests (PFTs) are a battery of tests that are used to assess how well a 
patient’s lungs are functioning. A type of PFT, Lung Spirometry, measures airflow by having a 
patient exhale into a mouthpiece that is connected to a spirometer. The spirometer measures the 
maximum amount of air that a patient can forcefully exhale, usually measured in an interval of 
seconds. Patient safety precautions must be taken into consideration during this battery of tests. 
Given that spirometry tests can be physically demanding, Miller et al recommends that patients 
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are made comfortable and placed in an environment that would mitigate the likelihood of injury 
through syncope. It is recommended that the patients remain seated while taking the tests. If a 
standing test is required, fall prophylaxis should be employed. It should be noted that the tests 
should try to replicate the conditions, in repeat testing, that were present in the first test. If the 
patient performed the lung spirometry testing while standing, they should perform the repeat 
testing in the standing position as well. Several important values are derived from this test that 
indicate the total amount of air expired and the total amount of air expired in one second, the 
forced vital capacity (FVC) and the forced expiratory volume in one second (FEV1). A ratio 
between the FVC and FEV1 is taken to and measured against a gold standard set by the 
American Thoracic Society. This standard stipulates that any FEV1/FVC value below 80% of the 
average FEV1/FVC ratio indicates that there is an obstructive or restrictive disease within the 
patient. Allergies come into play because chronic exacerbation can cause asthma, a restrictive 
lung disease. In a study conducted by Cushen et al, a cohort of Irish farmers was investigated for 
their prevalence of restrictive and obstructive lung diseases. Obstructive and restrictive disease 
were found in equal prevalence among smokers and non-smokers, with most these cases being 
related to allergies acquired in the workplace. The majority of these farmers were livestock 
farmers that were exposed to mildew and mold spores. There is further evidence to suggest that 
allergy-induced asthma, due to chronic exacerbations, still effect patients even outside of the 
allergy season. A study by Bake et al showed that patients that exhaled the highest quantity of 
nitrous oxide (an inflammation indicator) were patients that had allergy-related asthma due to 
pollen. These higher values of exhaled nitrous oxide also persisted out of the allergy season, 
indicating that the chronic allergy exacerbations lead to prolonged damage in the exchange 
surfaces within the lungs. Regarding spirometry, asthmatic patients compared to controls did not 
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have significantly differing FEV1/FVC values until subjected to bronchodilators. Upon 
subjecting the asthmatics to bronchodilators during the allergy season, these values changed 
slightly. Though this change was slight in the spirometry testing, it was significant. This change 
reinforces the previously mentioned chronic damage that allergies can perniciously inflict upon 
the exchange surfaces in the lungs. The data provided from the previous studies is lung 
spirometry testing from three different industries. These groups consist of Utility workers, 
Emergency Response personnel, and Boat Makers. This data will be examined using logistic 
regression and multiple linear regression. Logistic regression will be used to determine how 
much known pulmonary function predictor variables will lower FEV1/FVC ratios. Lung 
spirometry data sets will be divided up between the tree industries chosen and data points will be 
further sub-divided depending on allergy seasonings in the southeastern United States. Lung 
spirometry data within and between the three industries will be compared for the active allergy 
seasons and the inactive allergy seasons. The key is to determine if recorded FEV1/FVC ratios 
for workers being tested is, on average, lower during the allergy seasons. This would indicate 
that these workers with the lower ratios are, possibly, suffering from allergies which would 
reduce their overall FEV1/FVC ratios. Possible retesting for these workers in the future to 
compare spirometry values before and after bronchodilator use would be recommended. Further 
investigation into factors that normally change FEV1/FVC ratios such as age, weight, and height 
are suggested for future research should a significant correlation be found between allergy 
seasons and lowered values for these ratios. The primary allergens to be examined in this study 
are mold and pollen allergens. Being that these allergens follow the most distinct seasons, 
segregating the worker data for spirometry testing occurring during these allergy months would 
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be the most exact. Typically, outdoor airborne mold spores are at their peak from the months of 
May to November (Kołodziejczyk et al, 2016).  
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CHAPTER TWO: 
METHODS 
Lung spirometry data was taken from three separate industries in the southeastern United 
States. These three industries were general industry, emergency medical response, and 
shipwrights. The hypothesis that seasonal allergies lend to a decrease in spirometry scores was 
tested by segregating the data from each of these industries into four distinct allergy seasons. 
These seasons were decided using meteorological data from NOAA. Seasons were decided based 
upon the beginning and ending of solstices and equinoxes. For instance, the meteorological start 
date for summer would be the beginning of the summer solstice, which falls between June 21 
and 22. Under this convention, the allergy dates range between April 1st and end at November 
30th and the non-allergy dates start at December 1st and end at March 30th. However, adjustments 
were made to optimize statistical analysis. Being that most the PFTs were taken in November, 
under the previously prescribed convention, it left only 29 subjects in the non-allergy season and 
430 in the allergy season. To better fit the data, the date ranges were modified so that the non-
allergy season would begin November 1st and end March 30th. This led to a more evenly 
distributed data set, leaving 195 patients in the allergy season and 142 in the non-allergy season, 
and considering that November is on the cusp of the end of the allergy season, the potential for 
misclassification of subjects was limited. The frequency procedure was used in SAS to 
enumerate these populations, which are listed in Table 1 on page 12. After the data was properly 
segregated, Multiple Linear Regression and Logistic Regression were run using SAS on the 
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allergy and non-allergy seasons. Demographic variables were used for the regression analysis 
and included: Race (African American, Caucasian, and Hispanic), Height at test (above or below 
the median), smoking history (yes/no), Sex, FVC score above or below 80, age (above or below 
the median) and FEV1 score above or below 80. Odds ratios were also calculated to determine 
the likelihood that each variable would impart on the odds of scoring above or below the PFT 
score of 80. FVC/FEV1 scores below 80 were considered abnormal regarding pulmonary 
function. 
After the data was properly segregated, Multiple Linear Regression and Logistic 
Regression were run using SAS on the allergy and non-allergy seasons. Demographic variables 
were used for the regression analysis and included: Race (African American, Caucasian, and 
Hispanic), Height at test (above or below the median), smoking history (yes/no), Sex, FVC score 
above or below 80, age (above or below the median) and FEV1 score above or below 80. Odds 
ratios were also calculated to determine the likelihood that each variable would impart on the 
odds of scoring above or below the PFT score of 80. FVC/FEV1 scores below 80 percent 
predicted were considered abnormal regarding pulmonary function. 
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CHAPTER THREE: 
RESULTS 
The Frequency procedure in SAS was used again to enumerate the populations 
demographic variables and divide them into allergy season versus non-allergy season. This 
showed that the baseline data had some discrepancies between the allergy and non-allergy 
seasons regarding variable distribution. In the Table 2 on page 8, it was found that there were 
slightly more females in the non-allergy season than in the allergy season, 28 compared to 13, 
respectively. The distribution between races was even, the only slight discrepancy that existed 
was that there were more African Americans in the allergy season versus the non-allergy season, 
17 compared to 7, respectively. Regarding smoking history, there were twice as many smokers in 
the allergy season than there were in the non-allergy season (80 vs. 40). Data by height revealed 
that there were more people taller than 70 inches in the allergy season than there were in the non-
allergy season, 116 compared to 67, respectively. The division of members scoring above and 
below 80% for FEV1 and FVC was an even distribution of 169 in the allergy season and 130 in 
the non-allergy season. These tables are listed below.  Logistic regression run on the data 
revealed promising results. Age was a significant predictor variable for determining FVC score. 
Smoking history and age were significant predictor variables in determining whether a subject’s 
FEV1 score would be below eighty percent. Multiple linear regression results revealed a subtle 
linear effect for seasonality, a Pr>F value of 0.0002 in regards to FVC score. Age was also had a 
linear effect on FVC score, with a Pr>F score of <0.0001. Linear effects for FEV1 were found in 
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the age variable (0.0002 Pr>F), Sex (0.0139 Pr>F), Smoking history (0.0090 Pr>F), and in 
Season (0.0003 Pr>F). Season, for FEV1 had a subtle linear effect. These tables are listed below 
on pages 12 to 15. 
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CHAPTER FOUR: 
DISCUSSION 
The hypothesis posed at the beginning of this study was proven to be correct. Seasonality 
had a subtle linear effect but was not a determining factor for whether or not a subject would 
have an abnormal PFT score. Age, sex, and smoking history are well-established biologically 
plausibilities and were expected to influence FEV1 scores.  
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CHAPTER FIVE: 
CONCLUSION 
Within the purview of this study, it was shown that seasonality is associated with a subtle 
modulation of lung function tests. While the data, using the convention for determining seasons 
in this study design, was evenly divided, there could perhaps be more a determining affect from 
seasonality during peak pollen seasons or among highly sensitive individuals. Also, while this 
study was focused solely on industries in the southeastern united states, results could vary over 
differing climates; however, further research would be necessary to verify this. 
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Table 1. Allergy Months 
Month Frequency Percent Cumulative Frequency Cumulative Percent 
11 83 24.63 83 24.63 
9 76 22.55 159 47.18 
3 44 13.06 203 60.24 
8 29 8.61 232 68.84 
4 26 7.72 258 76.56 
6 26 7.72 284 84.27 
10 20 5.93 304 90.21 
5 9 2.67 313 92.88 
7 9 2.67 322 95.55 
1 7 2.08 329 97.63 
12 5 1.48 334 99.11 
2 3 0.89 337 100 
Season Frequency Percent Cumulative Frequency Cumulative Percent 
Allergy 195 57.86 195 57.86 
Non-
Allergy 142 42.14 337 100 
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Table 2. Season by Sex 
Season Sex 
Allergy Male Female Total 
Frequency 182 13 195 
Percent 54.01 3.86 57.86 
Row Percent 93.33 6.67 
Column Percent 61.49 31.71 
Non-Allergy Male Female Total 
Frequency 114 28 142 
Percent 33.83 8.31 42.14 
Row Percent 80.28 19.72 
Column Percent 38.51 68.29 
Total 
296 41 337 
87.83 12.17 100 
Table 3. Season by Height 
Season Height 
Allergy >70 inches < 70 Inches Total 
Frequency 116 79 195 
Percent 34.42 23.44 57.86 
Row Percent 59.49 40.51 
Column Percent 63.39 51.3 
Non-Allergy >70 inches < 70 Inches Total 
Frequency 67 75 142 
Percent 19.88 22.26 42.14 
Row Percent 47.18 52.82 
Column Percent 36.61 48.7 
Total 
183 154 337 
54.3 45.7 100 
Table 5. Season by Smoking History 
Season Smoking History 
Allergy No Yes Total 
Frequency 115 80 195 
Percent 34.12 23.47 57.86 
Row Percent 58.97 41.03 
Column Percent 53 66.67 
Non-Allergy No Yes Total 
Frequency 102 40 142 
Percent 30.27 11.87 42.14 
Row Percent 71.83 28.17 
Column Percent 47 33.33 
Total 
217 120 337 
64.39 35.61 100 
Table 4. Season by Race 
Season Race 
Allergy Caucasian Hispanic 
African 
American Total 
Frequency 162 16 17 195 
Percent 48.07 4.75 5.04 57.86 
Row Percent 83.08 8.21 8.72 
Column Percent 57.45 51.61 70.83 
Non-Allergy Caucasian Hispanic 
African 
American Total 
Frequency 120 15 7 142 
Percent 35.61 4.45 2.08 42.14 
Row Percent 84.51 10.56 4.93 
Column Percent 42.55 48.39 29.17 
Total 
282 31 24 337 
83.68 9.2 7.12 100 
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Table 6. Season by FVC 
Season FVC 
Allergy > 80% < 80% Total 
Frequency 169 26 195 
Percent 50.15 7.72 57.86 
Row Percent 86.67 13.33 
Column Percent 56.33 70.27 
Non-Allergy > 80% < 80% Total 
Frequency 131 11 142 
Percent 38.87 3.26 42.14 
Row Percent 92.25 7.75 
Column Percent 43.67 29.73 
Total 
300 37 337 
89.02 10.98 100 
Table 7. Season by FEV1 
Season FEV1 
Allergy > 80% < 80% Total 
Frequency 169 26 195 
Percent 50.15 7.72 57.86 
Row Percent 86.67 13.33 
Column Percent 56.52 68.42 
Non-Allergy > 80% < 80% Total 
Frequency 130 12 142 
Percent 38.58 3.56 42.14 
Row Percent 91.55 8.45 
Column Percent 43.48 31.58 
Total 
299 38 337 
88.72 11.28 100 
Table 9. Odds Ratio Estimates, FEV1* 
Effect Point Estimate 
95% Wald 
Confidence 
Limits 
Age 1.091 1.048 1.135 
Sex 1.229 0.300 5.03 
Caucasian vs. 
All others 0.943 0.300 2.963 
Smoking 
History Yes 
vs. No 0.373 0.18 0.771 
Height 1.029 0.897 1.181 
Allergy vs. 
Non-Allergy 0.682 0.311 1.493 
*to produce <80% predicted FVC or Abnormal
pulmonary Function 
Table 8. Odds Ratio Estimates, FVC* 
Effect Point Estimate 
95% Wald 
Confidence 
Limits 
Age 1.071 1.031 1.13 
Sex 0.215 0.024 1.885 
Caucasian vs. 
All others 0.835 0.269 2.588 
Smoking 
History Yes 
vs. No 0.753 0.366 1.55 
Height 1.003 0.876 1.148 
Allergy vs. 
Non-Allergy 0.664 0.307 1.436 
*to produce <80% predicted FVC or Abnormal
pulmonary Function 
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Table 10. Multiple Linear Regression: FEV1 
Source DF 
Parameter 
Estimate Type I SS Mean Square 
F 
Value Pr > F 
Age 1 -0.28035 3668.952 3668.952 13.94 0.0002 
Sex 1 1.16993 1608.354 1608.354 6.11 0.0139 
White vs. all others 1 -0.23938 40.353 40.353 0.15 0.6957 
Smoking History (Y/N) 1 -3.83109 1817.146 1817.146 6.9 0.0090 
Height 1 -0.58491 795.320 795.320 3.02 0.0831 
Season (Allergy/ Non-allergy 1 -6.78501 3574.262 3574.262 13.58 0.0003 
Table 11. Multiple Linear Regression: FVC 
Source DF 
Parameter 
Estimate Type I SS Mean Square 
F 
Value Pr > F 
Age 1 -0.35702 5837.352 5837.352 25.09 <0.0001 
Sex 1 3.73278 2626.809 2626.809 11.29 0.0009 
White vs. all others 1 -3.10984 577.252 577.252 2.48 0.1162 
Smoking History (Y/N) 1 -1.58466 507.731 507.731 2.18 0.1406 
Height 1 -0.47917 531.251 531.251 2.28 0.1317 
Season (Allergy/ Non-
allergy 1 -6.62142 3403.985 3403.985 14.63 0.0002 
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